Skip to content

Drug interactions

Ifosfamide + Lomitapide

Severity: Moderate

Ifosfamide and Lomitapide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ifosfamide is a weak CYP3A4 inhibitor and lomitapide is a CYP3A4 substrate, so lomitapide exposure could rise modestly. This may increase gastrointestinal effects and hepatotoxicity risk.

What this interaction means in plain words

Ifosfamide and Lomitapide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ifosfamide belongs to Oncology; Lomitapide belongs to Cardiovascular.

Evidence level: Low

Why it happens

Possible weak CYP3A4 inhibition by ifosfamide reduces lomitapide clearance.

What to do

Monitor liver enzymes and tolerability, and keep the lomitapide dose within the labeled limit for weak CYP3A4 inhibitors.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ifosfamide and Lomitapide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ifosfamide with Lomitapide?

MediHelp rates the interaction as moderate. Ifosfamide and Lomitapide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ifosfamide is a weak CYP3A4 inhibitor and lomitapide is a CYP3A4 substrate, so lomitapide exposure could rise modestly. This may increase gastrointestinal effects and hepatotoxicity risk.

How serious is the interaction between Ifosfamide and Lomitapide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver enzymes and tolerability, and keep the lomitapide dose within the labeled limit for weak CYP3A4 inhibitors.

What other medicines interact with Ifosfamide?

MediHelp also lists interactions of Ifosfamide with, for example, Adenovirus types 4 and 7 live, Measles mumps and rubella vaccine, Measles mumps and rubella vaccine live. The full list is on the Ifosfamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in